Retreatment with 24-week course of interferon-alpha for patients with chronic hepatitis C

被引:2
作者
Hagiwara, H [1 ]
Hayashi, N [1 ]
Oshita, M [1 ]
Katayama, K [1 ]
Kasahara, A [1 ]
Fusamoto, H [1 ]
Kamada, T [1 ]
机构
[1] OSAKA UNIV,SCH MED,DEPT MED 1,SUITA,OSAKA 565,JAPAN
来源
INTERNATIONAL HEPATOLOGY COMMUNICATIONS | 1996年 / 5卷 / 02期
关键词
hepatitis C virus RNA; antiviral therapy; interferon therapy; level of viremia;
D O I
10.1016/0928-4346(96)00291-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Twenty-nine patients with chronic hepatitis C were retreated with a 24-week course of natural interferon-a to evaluate the efficacy of retreatment with interferon for patients who were resistant to previous therapy. At 6 months after the end of retreatment, three patients (10%) had achieved sustained alanine aminotransferase normalization and sustained clearance of hepatitis C virus RNA in serum. Fifteen patients (52%) showed alanine aminotransferase normalization during retreatment but suffered from relapse during the 24 weeks after retreatment. In 11 patients (38%), no significant decrease of alanine aminotransferase was observed during and after retreatment. Three of ten patients with hepatitis C virus RNA of 2.3 x 10(5) equivalents/ml or less became sustained responders but none of the patients with a higher virus level achieved a sustained response. These results indicate that retreatment with a 24-week course of interferon is not efficient and other approaches are needed to attain a higher rate of sustained response, especially in patients with high viral load.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 18 条
[1]   TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALFA - A MULTICENTER RANDOMIZED, CONTROLLED TRIAL [J].
DAVIS, GL ;
BALART, LA ;
SCHIFF, ER ;
LINDSAY, K ;
BODENHEIMER, HC ;
PERRILLO, RP ;
CAREY, W ;
JACOBSON, IM ;
PAYNE, J ;
DIENSTAG, JL ;
VANTHIEL, DH ;
TAMBURRO, C ;
LEFKOWITCH, J ;
ALBRECHT, J ;
MESCHIEVITZ, C ;
ORTEGO, TJ ;
GIBAS, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1501-1506
[2]   RECOMBINANT INTERFERON-ALFA THERAPY FOR CHRONIC HEPATITIS-C - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DIBISCEGLIE, AM ;
MARTIN, P ;
KASSIANIDES, C ;
LISKERMELMAN, M ;
MURRAY, L ;
WAGGONER, J ;
GOODMAN, Z ;
BANKS, SM ;
HOOFNAGLE, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1506-1510
[3]   DETECTION OF HEPATITIS-C-VIRUS RNA IN CHRONIC NON-A, NON-B LIVER-DISEASE [J].
HAGIWARA, H ;
HAYASHI, N ;
MITA, E ;
HIRAMATSU, N ;
UEDA, K ;
TAKEHARA, T ;
YUKI, N ;
KASAHARA, A ;
FUSAMOTO, H ;
KAMADA, T .
GASTROENTEROLOGY, 1992, 102 (02) :692-694
[4]   QUANTITATION OF HEPATITIS-C VIRUS-RNA IN SERUM OF ASYMPTOMATIC BLOOD-DONORS AND PATIENTS WITH TYPE-C CHRONIC LIVER-DISEASE [J].
HAGIWARA, H ;
HAYASHI, N ;
MITA, E ;
NAITO, M ;
KASAHARA, A ;
FUSAMOTO, H ;
KAMADA, T .
HEPATOLOGY, 1993, 17 (04) :545-550
[5]   DETECTION OF HEPATITIS-C VIRUS-RNA IN SERUM OF PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITH INTERFERON-ALPHA [J].
HAGIWARA, H ;
HAYASHI, N ;
MITA, E ;
UEDA, K ;
TAKEHARA, T ;
KASAHARA, A ;
FUSAMOTO, H ;
KAMADA, T .
HEPATOLOGY, 1992, 15 (01) :37-41
[6]   QUANTITATIVE-ANALYSIS OF HEPATITIS-C VIRUS-RNA IN SERUM DURING INTERFERON ALFA THERAPY [J].
HAGIWARA, H ;
HAYASHI, N ;
MITA, E ;
TAKEHARA, T ;
KASAHARA, A ;
FUSAMOTO, H ;
KAMADA, T .
GASTROENTEROLOGY, 1993, 104 (03) :877-883
[7]  
HOFFNAGLE JH, 1986, NEW ENGL J MED, V315, P1575
[8]   A MULTIVARIATE-ANALYSIS OF RISK-FACTORS FOR HEPATOCELLULAR CARCINOGENESIS - A PROSPECTIVE OBSERVATION OF 795 PATIENTS WITH VIRAL AND ALCOHOLIC CIRRHOSIS [J].
IKEDA, K ;
SAITOH, S ;
KOIDA, I ;
ARASE, Y ;
TSUBOTA, A ;
CHAYAMA, K ;
KUMADA, H ;
KAWANISHI, M .
HEPATOLOGY, 1993, 18 (01) :47-53
[9]  
KANAZAWA Y, 1994, HEPATOLOGY, V20, P112
[10]   ABILITY OF PROLONGED INTERFERON TREATMENT TO SUPPRESS RELAPSE AFTER CESSATION OF THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C - A MULTICENTER RANDOMIZED CONTROLLED TRIAL [J].
KASAHARA, A ;
HAYASHI, N ;
HIRAMATSU, N ;
OSHITA, M ;
HAGIWARA, H ;
KATAYAMA, K ;
KATO, M ;
MASUZAWA, M ;
YOSHIHARA, H ;
KISHIDA, Y ;
SHIMIZU, Y ;
INOUE, A ;
FUSAMOTO, H ;
KAMADA, T .
HEPATOLOGY, 1995, 21 (02) :291-297